Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0350
+0.0010 (2.94%)
Jul 10, 2026, 4:10 PM AEST
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 57.11 million as of July 10, 2026. Its market cap has increased by 36.87% in one year.
Market Cap
57.11M
Enterprise Value
51.35M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 57.11M, an increase of 50.06%. That is a compound annual growth rate of 21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 57.11M | 10.97% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 89.33M |
| Avecho Biotechnology | 84.27M |
| Arovella Therapeutics | 79.78M |
| Prescient Therapeutics | 75.71M |
| Immutep | 75.16M |
| Amplia Therapeutics | 74.43M |
| Radiopharm Theranostics | 67.34M |
| Botanix Pharmaceuticals | 65.62M |